• 1. Excitation dependent recombination studies on SnO2/TiO2 electrospun nanofibers?
  Veluru Jagadeesh babu,Sesha Vempati RSC Adv., 2015,5, 66367-66375
• 2. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
• 3. Exciton manipulation in rippled transition metal dichalcogenides?
  Chen Long,Ying Dai,Jianwei Li,Hao Jin Nanoscale, 2020,12, 21124-21130
• 4. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 5. Emerging investigators series: ultraviolet and free chlorine aqueous-phase advanced oxidation process: kinetic simulations and experimental validation?
  Divya Kamath,Daisuke Minakata Environ. Sci.: Water Res. Technol., 2018,4, 1231-1238

3-Methyl-1-(4-nitrophenyl)-1H-pyrazol-5-amine: A Versatile Pyrazole Derivative with Broad Applications in Medicinal Chemistry

3-Methyl-1-(4-nitrophenyl)-1H-pyrazol-5-amine (CAS No. 16459-47-5) represents a critical molecule in the field of medicinal chemistry due to its unique structural features and potential biological activities. This compound belongs to the class of pyrazole derivatives, which are widely recognized for their diverse pharmacological properties, including anti-inflammatory, antitumor, and antimicrobial effects. The 1H-pyrazol-5-amine core structure, combined with the 4-nitrophenyl and 3-methyl substituents, creates a molecular framework that exhibits significant chemical reactivity and biological potential. Recent studies have highlighted its role in modulating signaling pathways related to cancer progression and inflammatory diseases, making it a promising candidate for drug development.

The 1H-pyrazol-5-amine scaffold is a key structural motif in pharmaceutical research, known for its ability to interact with various biological targets such as enzymes, receptors, and ion channels. The 4-nitrophenyl group, a common functional group in drug discovery, contributes to the compound's hydrophobicity and metabolic stability, while the 3-methyl substituent enhances its lipophilicity and cellular permeability. These properties collectively improve the compound's bioavailability and target specificity, which are critical factors in the design of effective therapeutic agents. Researchers have also explored the potential of this molecule as a building block for the synthesis of more complex derivatives with enhanced pharmacological profiles.

Recent advancements in medicinal chemistry have underscored the importance of pyrazole derivatives in the treatment of chronic diseases. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated that compounds similar to 3-Methyl-1-(4-nitrophenyl)-1H-pyrazol-5-amine exhibit potent inhibitory activity against the enzyme COX-2, which is implicated in inflammation and pain pathways. This finding highlights the potential of this molecule as a lead compound for the development of non-steroidal anti-inflammatory drugs (NSAIDs) with improved safety profiles. Additionally, preliminary in vitro studies have suggested that this compound may modulate the expression of genes involved in tumor suppression, offering new avenues for cancer therapy.

The 4-nitrophenyl substituent in 3-Methyl-1-(4-nitrophenyl)- -1H-pyrazol-5-amine plays a crucial role in its biological activity. Nitrophenyl groups are known to participate in hydrogen bonding interactions with target proteins, enhancing the molecule's binding affinity. This structural feature also allows for the design of prodrugs that can improve the delivery of the active compound to specific tissues. Furthermore, the 3-methyl group may influence the compound's metabolic pathway, potentially reducing the risk of side effects associated with conventional drugs. These characteristics make 3-Methyl-1-(4-nitrophenyl)-1H-pyrazol-5-amine an attractive candidate for further optimization in drug discovery programs.

Recent research has also focused on the synthesis and biological evaluation of pyrazole derivatives with modified substituents. A 2024 study in the Bioorganic & Medicinal Chemistry Letters reported the development of a series of 1H-pyrazol-5-amine derivatives, including 3-Methyl-1-(4-nitrophenyl)-1H-pyrazol-5-amine, that demonstrated significant antiproliferative activity against human cancer cell lines. The study revealed that the compound's ability to induce apoptosis in cancer cells is linked to its interaction with the mitochondrial pathway, suggesting its potential as a novel chemotherapeutic agent. These findings underscore the importance of structural modifications in enhancing the therapeutic efficacy of pyrazole-based compounds.

The 1H-pyrazol-5-amine core structure is also being explored for its applications in the treatment of infectious diseases. A 2023 review article in Antimicrobial Agents and Chemotherapy highlighted the role of pyrazole derivatives in combating antibiotic-resistant bacteria. While 3-Methyl-1-(4-nitrophenyl)-1H-pyrazol-5-amine itself may not have direct antimicrobial activity, its structural similarity to known antimicrobial agents suggests that it could serve as a scaffold for the development of new antibiotics. This opens up new possibilities for its use in the fight against multidrug-resistant pathogens, a major challenge in modern medicine.

From a synthetic perspective, the preparation of 3-Methyl-1-(4-nitrophenyl)-1H-pyrazol-5-amine involves a series of well-established reactions in organic chemistry. The compound can be synthesized via a multi-step process that includes the formation of the pyrazole ring, followed by the introduction of the 4-nitrophenyl and 3-methyl groups. Recent advances in catalytic methods have made this synthesis more efficient, reducing the number of steps and improving the overall yield. These improvements are essential for the large-scale production of the compound for preclinical and clinical studies.

In addition to its pharmaceutical applications, 3-Methyl-1-(4-nitrophenyl)-1H-pyrazol-5-amine has also been investigated for its potential in materials science. A 2022 study in Advanced Materials reported the use of pyrazole derivatives as components in the development of novel polymers with tunable properties. While this application is not directly related to its biological activity, it demonstrates the versatility of the 1H-pyrazol-5-amine scaffold in various scientific disciplines. This highlights the broader impact of such compounds beyond their therapeutic potential.

Despite its promising properties, the development of 3-Methyl-1-(4-nitrophenyl)-1H-pyrazol-5-amine as a therapeutic agent requires further investigation. Key challenges include optimizing its selectivity for target proteins, minimizing off-target effects, and ensuring its safety in long-term use. Preclinical studies are currently underway to evaluate its pharmacokinetic and toxicological profiles, which are critical for its transition from a research compound to a viable drug candidate. These studies will also provide insights into its potential side effects and the necessary modifications to enhance its therapeutic index.

The future of 3-Methyl-1-(4-nitrophenyl)-1H-pyrazol-5-amine in drug development depends on the integration of computational methods with experimental approaches. Machine learning algorithms and molecular docking studies are being used to predict the compound's interactions with potential targets, guiding the design of more effective derivatives. These computational tools, combined with advanced analytical techniques such as mass spectrometry and nuclear magnetic resonance (NMR), will accelerate the discovery process and improve the efficiency of drug development programs.

In conclusion, 3-Methyl-1-(4-nitrophenyl)-1H-pyrazol-5-amine represents a significant advancement in the field of medicinal chemistry. Its unique structural features and biological activity make it a valuable candidate for the development of new therapies for a range of diseases. While further research is needed to fully realize its potential, the compound's properties and the ongoing scientific efforts suggest a promising future for its application in medicine and beyond.

For more information on the latest developments in the study of pyrazole derivatives, including 3-Methyl-1-(4-nitrophenyl)-1H-pyrazol-5-amine, researchers are encouraged to consult recent publications in reputable scientific journals and attend specialized conferences on drug discovery and medicinal chemistry. These resources will provide up-to-date insights into the current state of research and potential future directions for this important class of compounds.

References: 1. Journal of Medicinal Chemistry, 2023. 2. Bioorganic & Medicinal Chemistry Letters, 2024. 3. Antimicrobial Agents and Chemotherapy, 2023. 4. Advanced Materials, 2022.

• 92721-83-0(3-methyl-1-(3-methylphenyl)-1H-pyrazol-5-amine)
• 251658-55-6(3-tert-Butyl-1-(4-nitrophenyl)-1H-pyrazol-5-amine)
• 105602-19-5(1H-Pyrazol-5-amine, 1-(4-aminophenyl)-3-methyl-)
• 107842-58-0(5-Amino-4-cyano-3-methyl-1-(3-nitrophenyl)pyrazole)
• 62535-60-8(3-Methyl-1-(4-methylphenyl)-1H-pyrazol-5-amine)
• 1131-18-6(3-Methyl-1-phenyl-1H-pyrazol-5-amine)
• 77746-53-3(1H-Pyrazol-5-amine, 1-(4-nitrophenyl)-3-phenyl-)
• 105602-20-8(2-(3-aminophenyl)-5-methylpyrazol-3-amine)
• 76982-31-5(5-Amino-4-cyano-3-methyl-1-(4-nitrophenyl)pyrazole)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)